Macrocytic anemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Macrocytic anemia}}
{{Macrocytic anemia}}


{{CMG}}; {{AE}}  
{{CMG}} {{shyam}} {{AE}}{{ADS}}  
==Overview==
==Overview==
[[Megaloblastic anemia]] affects 2-4% of population. Patients of all age groups may develop [[megaloblastic anemia]]. The incidence of [[megaloblastic anemia]] increases with age. Males are more commonly affected by [[megaloblastic anemia]] than females.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*[[Megaloblastic anemia]] affects 2-4% of population.<ref name="urlAnemia, Macrocytic - StatPearls - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK459295/#article-17535.s3 |title=Anemia, Macrocytic - StatPearls - NCBI Bookshelf |format= |work= |accessdate=}}</ref><ref name="pmid29264027">{{cite journal |vauthors=Nagao T, Hirokawa M |title=Diagnosis and treatment of macrocytic anemias in adults |journal=J Gen Fam Med |volume=18 |issue=5 |pages=200–204 |date=October 2017 |pmid=29264027 |pmc=5689413 |doi=10.1002/jgf2.31 |url=}}</ref><ref name="pmid18085121">{{cite journal |vauthors=Khanduri U, Sharma A |title=Megaloblastic anaemia: prevalence and causative factors |journal=Natl Med J India |volume=20 |issue=4 |pages=172–5 |date=2007 |pmid=18085121 |doi= |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop [[megaloblastic anemia]].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The incidence of [[megaloblastic anemia]] increases with age.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[[Megaloblastic anemia]] commonly affects older age group.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Males are more commonly affected by [[megaloblastic anemia]] than females.<ref name="pmid7918735">{{cite journal |vauthors=Inelmen EM, D'Alessio M, Gatto MR, Baggio MB, Jimenez G, Bizzotto MG, Enzi G |title=Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study |journal=Aging (Milano) |volume=6 |issue=2 |pages=81–9 |date=April 1994 |pmid=7918735 |doi= |url=}}</ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===


===Developing Countries===
===Developing Countries===
*Megaloblastic anemia is more common in developing countries due to lack of resources.


==References==
==References==

Latest revision as of 23:15, 2 December 2018

Macrocytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Macrocytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Macrocytic anemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Macrocytic anemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Macrocytic anemia epidemiology and demographics

CDC on Macrocytic anemia epidemiology and demographics

Macrocytic anemia epidemiology and demographics in the news

Blogs on Macrocytic anemia epidemiology and demographics

Directions to Hospitals Treating Macrocytic anemia

Risk calculators and risk factors for Macrocytic anemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3]

Overview

Megaloblastic anemia affects 2-4% of population. Patients of all age groups may develop megaloblastic anemia. The incidence of megaloblastic anemia increases with age. Males are more commonly affected by megaloblastic anemia than females.

Epidemiology and Demographics

Incidence

Age

Gender

Developing Countries

  • Megaloblastic anemia is more common in developing countries due to lack of resources.

References

  1. "Anemia, Macrocytic - StatPearls - NCBI Bookshelf".
  2. Nagao T, Hirokawa M (October 2017). "Diagnosis and treatment of macrocytic anemias in adults". J Gen Fam Med. 18 (5): 200–204. doi:10.1002/jgf2.31. PMC 5689413. PMID 29264027.
  3. Khanduri U, Sharma A (2007). "Megaloblastic anaemia: prevalence and causative factors". Natl Med J India. 20 (4): 172–5. PMID 18085121.
  4. Inelmen EM, D'Alessio M, Gatto MR, Baggio MB, Jimenez G, Bizzotto MG, Enzi G (April 1994). "Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study". Aging (Milano). 6 (2): 81–9. PMID 7918735.

Template:WikiDoc Sources